ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wyoming » Internal Medicine

Top Internal Medicine Prescribers in Wyoming

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RENEE STIRLING M.D.

Internal Medicine

1,738

$160K

113
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$92
Average prescription price

Avg: $60

REBECCA DANFORTH M.D.

Internal Medicine

919

$79.8K

112
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$87
Average prescription price

Avg: $60

CORY STIRLING M.D.

Internal Medicine

1,928

$163K

135
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$85
Average prescription price

Avg: $60

EMILY KNOBLOCH MD

Internal Medicine

2,620

$217K

115
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $60

DEXTER CASTA M.D.

Internal Medicine

6,880

$550K

374
282 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$80
Average prescription price

Avg: $60

ARDELLA KEMMLER MD

Internal Medicine

3,054

$235K

205
178 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$77
Average prescription price

Avg: $60

MICHAEL MENOLASCINO MD

Internal Medicine

7,807

$587K

397
355 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $60

HUGH BATTY MD

Internal Medicine

22,671

$1.61M

590
468 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $60

DENNIS BUTCHER MD

Internal Medicine

2,853

$203K

211
185 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $60

DIMITER ORAHOVATS MD

Internal Medicine

4,845

$336K

329
246 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $60

MARTHA STEARN MD

Internal Medicine

3,533

$244K

178
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $60

RICHARD JONES MD

Internal Medicine

3,694

$245K

273
245 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $60

ROBERT WHITE D.O.

Internal Medicine

5,055

$332K

280
235 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $60

MICHAEL STRAHAN MD

Internal Medicine

15,982

$1.05M

680
562 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $60

THOMAS BURKE M.D.

Internal Medicine

5,444

$354K

269
250 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $60

JULIE CARLSON M.D.

Internal Medicine

3,264

$212K

292
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $60

IAN HUNTER M.D.

Internal Medicine

9,439

$608K

564
491 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $60

RONNY SANTOSA MD

Internal Medicine

2,582

$166K

151
110 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $60

CLINTON MCMAHILL M.D.

Internal Medicine

1,280

$80K

114
67 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $60

APARNA TAMIRISA M.D.

Internal Medicine

791

$48.6K

119
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $60

SAMEERA FAREED FARRUKH M.D.

Internal Medicine

7,785

$479K

282
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $60

BILL WILLIAMS M.D.

Internal Medicine

4,095

$250K

163
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $60

JOHN THALKEN MD

Internal Medicine

5,344

$325K

264
221 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $60

SARVIN EMAMI MD

Internal Medicine

5,882

$351K

325
266 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $60

MICHAEL MILLER MD

Internal Medicine

10,769

$641K

460
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank